Advances in Ginsenosides
This book collected recent innovative research and review articles on analytical techniques, production protocols, biotechnological tools, and new insights into bioactivities of ginsenosides including the effects on epithelial-mesenchymal transition, hippocampal neurogenesis and inflammation as well...
Saved in:
| Other Authors: | |
|---|---|
| Format: | Book Chapter |
| Published: |
Basel, Switzerland
MDPI - Multidisciplinary Digital Publishing Institute
2021
|
| Subjects: | |
| Online Access: | Get Fullteks DOAB: description of the publication |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| LEADER | 03713naaaa2201081uu 4500 | ||
|---|---|---|---|
| 001 | doab_20_500_12854_76845 | ||
| 005 | 20220111 | ||
| 020 | |a books978-3-0365-1952-4 | ||
| 020 | |a 9783036519531 | ||
| 020 | |a 9783036519524 | ||
| 024 | 7 | |a 10.3390/books978-3-0365-1952-4 |c doi | |
| 041 | 0 | |a English | |
| 042 | |a dc | ||
| 072 | 7 | |a M |2 bicssc | |
| 100 | 1 | |a Chen, Jen-Tsung |4 edt | |
| 700 | 1 | |a Chen, Jen-Tsung |4 oth | |
| 245 | 1 | 0 | |a Advances in Ginsenosides |
| 260 | |a Basel, Switzerland |b MDPI - Multidisciplinary Digital Publishing Institute |c 2021 | ||
| 300 | |a 1 electronic resource (264 p.) | ||
| 506 | 0 | |a Open Access |2 star |f Unrestricted online access | |
| 520 | |a This book collected recent innovative research and review articles on analytical techniques, production protocols, biotechnological tools, and new insights into bioactivities of ginsenosides including the effects on epithelial-mesenchymal transition, hippocampal neurogenesis and inflammation as well as on diseases such as ischemic stroke, autoimmune diseases, and allergic disorders. Additionally, the analysis through molecular docking and an overview of the Panax ginseng pharmacopuncture were also presented. | ||
| 540 | |a Creative Commons |f https://creativecommons.org/licenses/by/4.0/ |2 cc |4 https://creativecommons.org/licenses/by/4.0/ | ||
| 546 | |a English | ||
| 650 | 7 | |a Medicine |2 bicssc | |
| 653 | |a Ginseng berries | ||
| 653 | |a UPLC-QTOF/MS | ||
| 653 | |a HR-MAS NMR spectroscopy | ||
| 653 | |a ginsenoside | ||
| 653 | |a primary metabolite | ||
| 653 | |a notoginseng leaf triterpenes | ||
| 653 | |a HMGB1 | ||
| 653 | |a cerebral ischemia and reperfusion injury | ||
| 653 | |a inflammation | ||
| 653 | |a MAPK | ||
| 653 | |a NF-κB | ||
| 653 | |a Panax ginseng | ||
| 653 | |a wild ginseng | ||
| 653 | |a pharmacopuncture | ||
| 653 | |a safety | ||
| 653 | |a clinical trials | ||
| 653 | |a ocotillol type ginsenoside epimers | ||
| 653 | |a stereoselective ADME characteristics | ||
| 653 | |a molecular docking analysis | ||
| 653 | |a homology modeling | ||
| 653 | |a molecular interaction | ||
| 653 | |a Rg3 | ||
| 653 | |a Th17 | ||
| 653 | |a RORγt | ||
| 653 | |a EAE | ||
| 653 | |a Lactobacillus ginsenosidimutans | ||
| 653 | |a complete genome sequence | ||
| 653 | |a novel glycoside hydrolases | ||
| 653 | |a bioconversion | ||
| 653 | |a recombinant enzyme | ||
| 653 | |a ginsenoside Rg3(S) | ||
| 653 | |a gram unit production | ||
| 653 | |a Asian ginseng | ||
| 653 | |a American ginseng | ||
| 653 | |a Panax quinquefolium L. | ||
| 653 | |a ginsenosides | ||
| 653 | |a anti-inflammation | ||
| 653 | |a pro-resolving | ||
| 653 | |a ginseng | ||
| 653 | |a macrophage | ||
| 653 | |a M2 polarization | ||
| 653 | |a ginsenoside CK | ||
| 653 | |a neurogenesis | ||
| 653 | |a cell proliferation | ||
| 653 | |a neuroprotection | ||
| 653 | |a dammarane-type triterpene saponin | ||
| 653 | |a ginsenoside MT1 | ||
| 653 | |a transglycosylation | ||
| 653 | |a biotransformation | ||
| 653 | |a biotechnology | ||
| 653 | |a Anxa2 | ||
| 653 | |a epithelial-mesenchymal transition | ||
| 653 | |a (20S)G-Rh2 | ||
| 653 | |a bioreactor | ||
| 653 | |a cell suspension | ||
| 653 | |a hairy root | ||
| 653 | |a polyploidy | ||
| 653 | |a protoplast | ||
| 653 | |a Panax sp. | ||
| 653 | |a polysaccharides | ||
| 653 | |a allergy | ||
| 653 | |a immune system | ||
| 653 | |a n/a | ||
| 653 | |a compound M1 | ||
| 653 | |a hepatoprotective | ||
| 653 | |a anti-cancer | ||
| 653 | |a anti-diabetic | ||
| 856 | 4 | 0 | |a www.oapen.org |u https://mdpi.com/books/pdfview/book/4294 |7 0 |z Get Fullteks |
| 856 | 4 | 0 | |a www.oapen.org |u https://directory.doabooks.org/handle/20.500.12854/76845 |7 0 |z DOAB: description of the publication |